A Fully Owned Subsidiary of Sumitomo Offered to Buy the Remaining Outstanding Shares of ... - Latest Tweet by Bloomberg

A fully owned subsidiary of Sumitomo offered to buy the remaining outstanding shares of pharmaceutical company Myovant Sciences, seeking to bolster the development of drugs for women’s health and prostate cancer https://t.co/azEHohhvj6— Bloomberg (@business) October 3, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)